Results 151 to 160 of about 115,034 (330)

Low‐dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation – the RATE‐AF randomized trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Summary of the change in left ventricular systolic and diastolic parameters from baseline to 12 months in patients with permanent atrial fibrillation (AF) and a left ventricular ejection fraction (LVEF) ≥50%. P‐values indicate the significance of the adjusted mean difference of the parameters at 12 months between the beta‐blocker and digoxin arm. E/e′,
Karina V. Bunting   +10 more
wiley   +1 more source

Secondary Mitral Regurgitation: Diagnosis and Management

open access: yesUS Cardiology Review
Secondary mitral regurgitation is one of the most common valve diseases. The disease is a result of left atrial or left ventricular dysfunction. It is generally classified into stages based on its severity.
Nehal Dhaduk   +4 more
doaj   +1 more source

Early results after mitral valvuloplasty for pure mitral regurgitation [PDF]

open access: yes, 2017
In this study we present the results of 105 consecutive patients with pure mitral regurgitation who underwent surgical treatment. In all patients mitral regurgitation was associated with mitral valve prolapse: 54 patients underwent mitral valvuloplasty ...
EGLOFF, L.   +8 more
core  

A functional role for spontaneously occurring natural anti‐transthyretin antibodies from patients with transthyretin cardiac amyloidosis

open access: yes
European Journal of Heart Failure, EarlyView.
Ortal Tuvali   +5 more
wiley   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis   +11 more
wiley   +1 more source

A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides

open access: yes
European Journal of Heart Failure, EarlyView.
Jerremy Weerts   +13 more
wiley   +1 more source

A U‐shaped relationship between left ventricular ejection fraction and risk of worsening heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
A U‐shaped relationship between left ventricular ejection fraction (LVEF) and clinical outcomes. A U‐shaped relationship can be observed between LVEF, the primary outcome, and the cardiovascular‐related outcomes, including cardiovascular death and the risk of worsening heart failure (HF).
Hao‐Chih Chang   +9 more
wiley   +1 more source

Follow-up study of left heart valve regurgitation after implantation of left ventricular assist device

open access: yesZhongguo Linchuang Yixue
ObjectiveTo explore the valve regurgitation status of left heart after the implantation of left ventricular assist device (LVAD) and its effect on prognosis of patients with LVAD implantation.
Junjiang LIU   +8 more
doaj   +1 more source

Ventricular Approach for Functional Mitral Regurgitation in Cardiomyopathy

open access: hybrid, 2013
Kenji Minakata   +6 more
openalex   +2 more sources

A Case of Cerebral Air Embolization During Robot‐Assisted Partial Nephrectomy via a Retroperitoneal Approach for the Patient With Renal Cell Carcinoma

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction Cerebral air embolism accompanied by right‐to‐left shunt through the venous system during Robot‐assisted partial nephrectomy (RAPN) is regarded as a rare occurrence, with a high mortality rate. Case Presentation A case of a 77‐year‐old man with renal cell carcinoma who developed cerebral air embolism during right retroperitoneal ...
Takashi Matsumoto   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy